To include your compound in the COVID-19 Resource Center, submit it here.

Pediatric data add to Shire's ADHD package

Shire plc (LSE:SHP; NASDAQ:SHPG) said its SHP465 triple-bead mixed amphetamine salts (MAS) met the primary endpoint of improving ADHD symptoms in the Phase

Read the full 236 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE